C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis
The discovery of reliable cancer biomarkers could tune a diagnosis and improve the way patients are treated. However, many cancers lack robust biomarkers. has been preliminarily elucidated for its role in some tumors. However, no pan-cancer analysis has been performed to comprehensively explore the...
Saved in:
Published in | Frontiers in pharmacology Vol. 13; p. 855485 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
23.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The discovery of reliable cancer biomarkers could tune a diagnosis and improve the way patients are treated. However, many cancers lack robust biomarkers.
has been preliminarily elucidated for its role in some tumors. However, no pan-cancer analysis has been performed to comprehensively explore the value of
.
Data from the TCGA database, GTEx database stored in the USUC Xena were used for analyzing the profiles of
expression in normal and tumor tissues in pan-cancer. Subsequently, the gene alteration rates of
were acquired on the online web cBioportal. With the aid of the TCGA data, the association between
mRNA expression and copy number alterations (CNA) and methylation was determined. Survival analyses of
were carried out. Moreover, the tumor biological and immunological characteristics of
were clarified in the forms of the correlation between
expression and hallmark Pathway scores in MsigDB database, immune cell infiltration, immune-related genes. We conducted a GSEA of
to illustrate its potential biological functions. In addition, GDSC2 data with 198 drugs were adopted to explore drug sensitivity with the change of
expression.
was overexpressed in many types of cancer, Survival analysis showed that
independently served as a prognostic indicator for poor survival in many tumors. Besides, we also identified a positive correlation between
and cancer hallmark pathway score, tumor microenvironment related pathways score (TMEp score), and immune characteristic. In terms of drug sensitivity analysis, we found higher expression level of
predicts a high IC50 value for most of 198 drugs which predicts drug resistance.
Our study provides a new biological marker for pan-cancer, which is beneficial to the diagnosis and treatment of cancer, which bring a new therapeutic target for tumors. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Benhua Xu, Fujian Medical University Union Hospital, China Reviewed by: Qichun Wei, Zhejiang University, China These authors have contributed equally to this work This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology Edited by: Jian Zhang, Southern Medical University, China Md. Nazim Uddin, China Pharmaceutical University, China |
ISSN: | 1663-9812 1663-9812 |
DOI: | 10.3389/fphar.2022.855485 |